The expansion of the fertility services market is anticipated to be fuelled by developments in assisted reproductive technology, increased awareness of infertility treatments, and an increase in the number of fertility clinics.
SAN DIEGO, Sept. 21, 2022 (GLOBE NEWSWIRE) — Recent study report released by Data Bridge Market research titled “Global Fertility Services Market” (covering USA, Europe, China, Japan, India, South East Asia, etc) highlights opportunities, risk analysis, and leveraged with strategic and tactical decision-making support. The fertility Services market is a valuable document for every market enthusiast, policymaker, investor, and market player. The fertility Services market report analyses the key developments taking place concerning agreements, partnerships, collaborations, and joint ventures, acquisitions & mergers, new product launches, expansions, and other key strategies. It also studies detailed company profiling. The overviews, SWOT analysis, and strategies of each vendor covered in the Fertility Services market research report provide an understanding of the market forces and how those can be exploited to create future opportunities.
Data Bridge Market Research analyses that the fertility services market which was USD 17.45 billion in 2021, would rocket up to USD 31.59 billion by 2029, and is expected to undergo a CAGR of 7.70% during the forecast period 2022 to 2029. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Get Sample PDF Brochure (Including Graphs, Charts & Figures) @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-fertility-services-market
The services that those who are unable to conceive naturally use are known as fertility services. These fertility services aid infertile couples, single parents, LGBT people, and anyone who is having trouble getting pregnant. Treatment methods for genetic disorders and infertility concerns are included in fertility treatments to aid in conception.
Services related to fertility are offered to help in infertility treatment. These services use methods such in vitro fertilisation (IVF), artificial insemination, surrogacy, and others to aid couples, single mothers, and members of the LGBT community who are having trouble getting pregnant. Men and women of childbearing age can both experience infertility. Additionally, reduced sperm counts or decreased sperm motility, which may be caused by hormonal imbalance, are primary causes of male infertility. Therefore, the hypothalamus and pituitary gland must work properly for both men and women to be fertile.
Opportunities
According to research by the American Society for Reproductive Medicine, the male spouse causes infertility in about 40% of infertile couples, and among them, between 85 and 90 percent are cured with medication or surgery. This is expected to fuel the fertility services market size
Some of the major players operating in the fertility services market are:
Olympus Corporation (Japan)
The Cooper Companies Inc. (U.S.)
Instituto Bernabeu (Spain)
Virtus Health (Australia)
CooperSurgical, Inc. (U.S.)
Vitrolife (Sweden)
CARE Fertility (U.K.)
INVO Bioscience (U.S.)
Monash IVF (Australia)
Fertility Focus Limited (U.S.)
Carolinas Fertility Institute (U.S.)
Apollo Hospitals Enterprise Ltd. (India)
Fertility Services report is a wide-ranging market research report which studies the challenges, market structures, opportunities, driving forces, emerging trends, and competitive landscape of healthcare industry. Moreover, the report revises general market conditions, estimates market share and possible sales volume of the healthcare industry, figure out the probable market for a new product to be launched and discover the most appropriate method for the distribution of certain product. By taking into consideration specific base year and historic year, calculations in the report have been performed which interprets the market performance in the forecast years by giving information about what the market definition, classifications, applications, and engagements are.
Grab Full 350 Pages PDF Research Report @ https://www.databridgemarketresearch.com/checkout/buy/enterprise/global-fertility-services-market
Recent Development
In July 2019, A Queensland-based provider of reproductive treatments named Fertility Solutions was purchased by Australia-based Monash IVF Group for $1.43 million (AUD 2.1 million). The business purchased some of Fertility Solutions’ assets, liabilities, and contracts. With two Fertility Solutions facilities in Bundaberg and the Sunshine Coast, the acquisition is anticipated to increase Monash IVF Group’s regional reach.
The Analysis Objectives Of The Report Are:
To know this fertility services market size by pinpointing its sub-sections
To investigate the sum and estimation of this Market, contingent upon key areas
To consider the significant players and investigate their development plans
To investigate this Market concerning development patterns, possibilities, and their interest in the whole area
To analyze this market size (volume and worth) from the organization, basic locales/nations, items and application, foundation data
Essential overall this Market fabricating organizations, to indicate, explain, and examine the item deals sum, worth and piece of the pie, market contention scene, SWOT investigation, and improvement plans for future.
Industry Segmentation: Fertility Services Market
The fertility services market is segmented based on infertility, procedure, services and end-user. The growth amongst these segments will help you analyze meager growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Infertility
Male infertility
Female infertility
Procedure
Assisted Reproductive Technology (ART)
In-Vitro Fertilization
Artificial Insemination
Surrogacy
Services
Donor
Non-donor
End-User
Fertility Clinics
Hospitals
Clinical Research Institutes
Surgical Centers
Fertility Services Market, By Region:
The fertility Services market is analyzed and market size insights and trends are provided by country, and product as referenced above.
The countries covered in the Fertility Services market report are the U.S., Canada, and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of the Middle East and Africa (MEA) as a part of the Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the Fertility Services market because of the rise in the cases of arrhythmic diseases, favorable reimbursement policies for patients, high demand for advanced treatment methods, and developed healthcare infrastructure in the region. Asia-Pacific is estimated to grow in the forecast period due to the high prevalence of cardiovascular diseases, increase in adoption of advanced digital devices, large population and launch of new innovative products.
Browse More About This Research Report @ https://www.databridgemarketresearch.com/reports/global-fertility-services-market
Fertility Services Market Dynamics:
Drivers
Rising technological advancements
Growing technological advancements in fertility treatment, rising success rates with ICSI-IVF in cases of poor sperm morphology, poor sperm motility, and low sperm count in men, rising accessibility and availability of healthcare facilities, and rising healthcare and research spending are the main factors among others driving the fertility market.
Rising delayed pregnancies in women
Rising delayed pregnancies in women are the key factor escalating the market growth. Additionally, in the anticipated period of 2022–2029, rising technical developments, modernization, and research and development activities in the healthcare sector will further generate new chances for the market for fertility services.
Increased awareness of infertility treatments
The expansion of the fertility services market is anticipated to be fuelled by developments in assisted reproductive technology, increased awareness of infertility treatments, and an increase in the number of fertility clinics.
TABLE OF CONTENTS
Part 01: Executive Summary
Part 02: Scope Of The Report
Part 03: Research Methodology
Part 04: Market Landscape
Part 05: Pipeline Analysis
Part 06: Market Sizing
Part 07: Five Forces Analysis
Part 08: Market Segmentation
Part 09: Customer Landscape
Part 10: Regional Landscape
Part 11: Decision Framework
Part 12: Drivers And Challenges
Part 13: Market Trends
Part 14: Vendor Landscape
Part 15: Vendor Analysis
Part 16: Appendix
Check Complete Table of Contents with List of Table and Figures @ https://www.databridgemarketresearch.com/toc/?dbmr=global-fertility-services-market
Explore More Reports:-
Infertility Treatment Market, By Sex (Males, Females and Unexplained), Diagnosis (Men Diagnostic Tests, Women Diagnostic and General Diagnostic Tests), Drugs (Clomiphene Citrate, Letrozole, Serophene, Hormone Treatment and Others), Techniques (Assisted Reproductive Technology (ART), Intrauterine Insemination, and Surgery) https://www.databridgemarketresearch.com/reports/global-infertility-treatment-market
Fertility Testing Devices Market, By Product (Ovulation Prediction Kit, Fertility Monitor), Mode of Purchase (Over the Counter, Prescription Based), Application (Female Fertility Testing Device, Male Fertility Testing Device), End-User (Home Care Settings, Hospitals, Fertility Clinics, Others) https://www.databridgemarketresearch.com/reports/global-fertility-testing-devices-market
Asia-Pacific Fertility Testing Devices Market, By Mode of Purchase (Over The Counter, Prescription Based), Application (Female Fertility Testing Device, Male Fertility Testing Device), Product (Ovulation Prediction Kit, Fertility Monitor), End-User (Home Care Settings, Hospitals, Fertility Clinics, Others), Country (China, South Korea, Japan, India, Australia, Singapore, Malaysia, Indonesia, Thailand, Philippines, Rest of Asia-Pacific) https://www.databridgemarketresearch.com/reports/asia-pacific-fertility-testing-devices-market
Europe Fertility Testing Devices Market, By Mode of Purchase (Over the Counter and Prescription Based), Application (Female Fertility Testing Device and Male Fertility Testing Device), Product (Ovulation Prediction Kit and Fertility Monitor), End-User (Home Care Settings, Hospitals, Fertility Clinics and Others), Country (Germany, U.K., France, Italy, Spain, Netherlands, Russia, Switzerland, Rest of Europe) https://www.databridgemarketresearch.com/reports/europe-fertility-testing-devices-market
Infertility Testing Market, By Type (Female Infertility Testing, Male Infertility Testing), Test Kits (Follicular Stimulating Hormone (FSH) Urine Test Kits, Luteinizing Hormone (LH) Urine Test Kits, Human Chorionic Gonadotropin (HCG) Hormone Blood Test Kits, Others), Prescription Mode (Prescription Based, Over The Counter (OTC) Based), Distribution Channel (Hospitals Pharmacies, Online Pharmacies, Pharmacies & Drug Stores), End Users (Fertility Centres, Hospitals and Clinics, Research Institutes, Cryobanks) https://www.databridgemarketresearch.com/reports/global-infertility-testing-market
North America Infertility Testing Market, By Type (Female Infertility Testing, Male Infertility Testing), Test Kits (Human Follicular Stimulating Hormone (FSH) Urine Test Kits, Luteinizing Hormone (LH) Urine Test Kits, Human Chorionic Gonadotropin (HCG) Hormone Blood Test Kits, Others), Prescription Mode (Prescription-Based, Over The Counter (OTC) Based), Distribution Channel (Hospitals Pharmacies, Online Pharmacies, Pharmacies and Drug Stores), End Use (Fertility Centers, Hospitals And Clinics, Research Institutes, Cryobanks), Country (U.S., Canada, Mexico) https://www.databridgemarketresearch.com/reports/north-america-infertility-testing-market
Europe Infertility Testing Market, By Type (Female Infertility Testing and Male Infertility Testing), Test Kits (Human Follicular Stimulating Hormone (FSH) Urine Test Kits, Luteinizing Hormone (LH) Urine Test Kits, Human Chorionic Gonadotropin (HCG) Hormone Blood Test Kits and Others), Prescription Mode (Prescription-Based and Over The Counter (OTC) Based), Distribution Channel (Hospitals Pharmacies, Online Pharmacies, Pharmacies and Drug Stores), End Use (Fertility Centers, Hospitals and Clinics, Research Institutes and Cryobanks), Country https://www.databridgemarketresearch.com/reports/europe-infertility-testing-market
Fertility Test Market, By Product (Ovulation Prediction Kit, Fertility Monitor, Male Fertility Testing Products, Others), Sample (Saliva, Urine, Blood, Others), Mode of Purchase (Over The Counter, Prescription Based), Application (Female, Male), End User (Hospitals, Homecare Settings, Fertility Clinics, Others), Country https://www.databridgemarketresearch.com/reports/global-fertility-test-market
About Data Bridge Market Research:
An absolute way to forecast what future holds is to comprehend the trend today!
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavours to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data Bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune.
Data Bridge Market Research has over 500 analysts working in different industries. We have catered more than 40% of the fortune 500 companies globally and have a network of more than 5000+ clientele around the globe. Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. We are content with our glorious 99.9 % client satisfying rate.
Contact Us:-
Data Bridge Market Research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475
Email:- corporatesales@databridgemarketresearch.com
Less than five months after discouraging conversations with the U.S. Food and Drug Administration led Spero Therapeutics Inc. to pause work on a drug and lay off 110 people, the company is licensing that same drug to GSK plc for up to $291 million.
UBS's Colin Bristow raised his rating on the stock to Buy from Neutral, saying Well Street's expectations for sales of Mounjaro are too low.
Shares of Bristol Myers Squibb (NYSE: BMY) were bouncing 3.4% higher as of 3:31 p.m. ET on Thursday after slipping a little earlier this week. Instead, today's move appeared to be the result of investors seeking relatively safe stocks as the Nasdaq Composite index and Russell 2000 small-cap index fell. Bristol Myers Squibb has seemed to be sort of a safe haven for investors throughout much of 2022.
This drugmaker has earned two new drug approvals in as many months, but its success isn't reflected in its market valuation yet.
Ionis stock tumbled Friday after partner AstraZeneca decided against sending their high cholesterol treatment into Phase 3 testing.
A potentially disruptive business model is finding its legs in the post-pandemic healthcare landscape.
Eli Lilly's blockbuster potential diabetes drug Mounjaro is "de-risked and transformative," an analyst said Thursday as he updated LLY stock.
Khosla Ventures is throwing its weight behind a new CRISPR/Cas13 startup, and Sesen Bio, formerly Eleven Biotherapeutics, is finally shutting down after 14 years.
OpSens Inc. ("OpSens" or the "Company") (TSX: OPS) (OTCQX: OPSSF), a medical device cardiology-focused company delivering innovative solutions based on its proprietary optical technology, today announced that Dr. Philippe Genereux, Director of the Structural Heart Program at Morristown Medical Center in New Jersey, and his team, performed the first use of SavvyWire in a transcatheter aortic valve replacement (TAVR) procedure in the United States.
AngioDynamics took a risk when it spent $66 million to acquire new laser technology that had yet to hit the market. Three years later, that bet is starting to pay off.
Pacira's (PCRX) phase III study evaluating its marketed drug, Exparel, as a single-dose sciatic nerve block in the popliteal fossa for bunionectomy meets primary and secondary endpoints.
The latest data from the RELIEF Study suggests a lower rate of hospitalizations from serious diabetes-related events with Abbott's (ABT) FreeStyle Libre system.
Healthcare exchange-traded funds (ETFs) invest in a basket of stocks of companies that provide medical services, develop medical equipment or drugs, offer medical insurance, or facilitate the provision of healthcare to patients.
Health experts said it is too early to predict whether demand would match up with the 171 million doses of the new boosters the U.S. ordered for the fall.
Think Research Corporation (TSXV: THNK) ("Think" or the "Company"), a company focused on transforming healthcare through integrated digital health software solutions, today announced that it has granted 350,000 restricted share units (each, an "RSU") to key employees of the Company pursuant to the Company's Omnibus Equity Incentive Plan. 300,000 of the RSUs will vest in one year, and the remaining 50,000 RSUs will vest 1/3 on September 30, 2023, 1/3 on December 31, 2023 and 1/3 on December 31, 2
Whether you work out at home or at the gym, it's important to commit to resistance training two or three times per week. Here's what else to know.
The negative vote dims chances for Oncopeptides’s treatment to return to the market, after the company pulled it in October 2021.
Many people have had COVID-19 by now, but they should still get an Omicron booster
In some instances, cancer patients who were denied treatment because of their pregnancies were also unable to receive abortions, an affidavit alleges
The vegetable was shown to lower blood sugar levels and cholesterol levels